Description of [CD8.sup.+] Regulatory T Lymphocytes and Their Specific Intervention in Graft-versus-Host and Infectious Diseases, Autoimmunity, and Cancer

• Published in: Journal of Immunology Research Vol. 2018
• Main Authors: Vieyra-Lobato, Martha R, Vela-Ojeda, Jorge, Montiel-Cervantes, Laura, Lopez-Santiago, Ruben, Moreno-Lafont, Martha C
• Format: Journal Article
• Language: English
• Published: John Wiley & Sons, Inc 01.01.2018
• ISSN: 2314-8861
• DOI: 10.1155/2018/3758713

Gershon and Kondo described [CD8.sup.+] Treg lymphocytes as the first ones with regulating activity due to their tolerance ability to foreign antigens and their capacity to inhibit the proliferation of other lymphocytes. Regardless, [CD8.sup.+] Treg lymphocytes have not been fully described--unlike [CD4.sup.+] Treg lymphocytes--because of their low numbers in blood and the lack of specific and accurate population markers. Still, these lymphocytes have been studied for the past 30 years, even after finding difficulties during investigations. As a result, studies have identified markers that define their subpopulations. This review is focused on the expression of cell membrane markers as CD25, CD122, CD103, CTLA-4, CD39, CD73, LAG-3, and FasL as well as soluble molecules such as FoxP3, IFN-[gamma], IL-10, TGF-[beta], IL-34, and IL-35, in addition to the lack of expression of cell activation markers such as CD28, CD127 CD45RC, and CD49d. This work also underlines the importance of identifying some of these markers in infections with several pathogens, autoimmunity, cancer, and graft-versus-host disease as a strategy in their prevention, monitoring, and cure.